Aurora Cannabis Inc. (ACB)
After hours:
| Previous Close | 2.9500 |
| Open | 2.9900 |
| Bid | 3.0500 x 34100 |
| Ask | 3.0900 x 38800 |
| Day's Range | 2.9700 - 3.1450 |
| 52 Week Range | 2.2000 - 10.6400 |
| Volume | |
| Avg. Volume | 7,332,143 |
| Market Cap | 612.667M |
| Beta (5Y Monthly) | 3.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Aurora Cannabis Announces Fiscal 2022 Third Quarter Results
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the third quarter fiscal 2022 ended March 31, 2022.
- CNW Group
Aurora Cannabis Advances Premiumization Strategy by Completing Acquisition of Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced it has completed its previously announced acquisition of TerraFarma Inc. (parent company of Thrive Cannabis) ("Thrive") (the "Transaction") for aggregate initial consideration of $38 million paid in cash and Aurora common shares ("Aurora Shares"), and up to $30 million in potential earnout amounts, payable in cash, Aurora Shares or a combi
- CNW Group
Aurora Cannabis to Host Third Quarter Fiscal Year 2022 Investor Conference Call
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its third quarter fiscal year 2022 on Thursday, May 12, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the third quarter fiscal year 2022 after the close of markets that same day.
